Future Regulatory Outlook: If ongoing Phase 23 trials in men demonstrate clear safety and efficacy, we could see an FDA submission for a male indication (for ED or another male sexual disorder) in a couple of years
Medical history, current medications, diabetes status, heart health, kidney health, stomach problems, insurance coverage, and weight goals all matter
Despite the FDA mandate, pharmacies have some legislative leeway based on dose and formulation tailoring, and certain companies are betting on this to stay active
Allergen Warning Manufactured by equipment which may process products containing milk, eggs, soy, wheat, shellfish, fish, tree nuts, peanuts, and sesame
10.1111/j.1365-313X.2012.05105.x 16 IqbalN.UmarS.KhanN